{"id":"https://openalex.org/W2159155203","doi":"https://doi.org/10.1056/nejmoa051688","title":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia","display_name":"Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia","publication_year":2005,"publication_date":"2005-09-19","ids":{"openalex":"https://openalex.org/W2159155203","doi":"https://doi.org/10.1056/nejmoa051688","mag":"2159155203","pmid":"https://pubmed.ncbi.nlm.nih.gov/16172203"},"language":"en","primary_location":{"id":"doi:10.1056/nejmoa051688","doi":"https://doi.org/10.1056/nejmoa051688","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa051688","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa051688?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa051688?articleTools=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075093461","display_name":"Jeffrey Alan Lieberman","orcid":"https://orcid.org/0000-0002-1899-1776","observed_orcids":["https://orcid.org/0000-0002-1899-1776"]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I4388891851"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Lieberman","raw_affiliation_strings":["Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA. jlieberman@columbia.edu","Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA. jlieberman@columbia.edu","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]},{"raw_affiliation_string":"Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York","institution_ids":["https://openalex.org/I4388891851","https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023756758","display_name":"T. Scott Stroup","orcid":"https://orcid.org/0000-0002-3123-0672","observed_orcids":["https://orcid.org/0000-0002-3123-0672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Scott Stroup","raw_affiliation_strings":["Department of Psychiatry, School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109121499","display_name":"Joseph P. McEvoy","orcid":"https://orcid.org/0000-0002-0047-5124","observed_orcids":["https://orcid.org/0000-0002-0047-5124"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph P. McEvoy","raw_affiliation_strings":["Department of Biological Psychiatry, John Umstead Hospital, Butner, N.C","Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, N.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Psychiatry, John Umstead Hospital, Butner, N.C","institution_ids":[]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, N.C","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103323158","display_name":"Marvin S. Swartz","orcid":"https://orcid.org/0000-0002-1111-9299","observed_orcids":["https://orcid.org/0000-0002-1111-9299"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marvin S. Swartz","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, N.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, N.C","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027752754","display_name":"Robert Alan Rosenheck","orcid":"https://orcid.org/0000-0003-4314-4592","observed_orcids":["https://orcid.org/0000-0003-4314-4592"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Rosenheck","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Conn"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Conn","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005838731","display_name":"Diana O. Perkins","orcid":"https://orcid.org/0000-0001-9396-2206","observed_orcids":["https://orcid.org/0000-0001-9396-2206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana O. Perkins","raw_affiliation_strings":["Department of Psychiatry, School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, School of Medicine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026643447","display_name":"Richard S.E. Keefe","orcid":"https://orcid.org/0000-0002-0173-8897","observed_orcids":["https://orcid.org/0000-0002-0173-8897"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard S.E. Keefe","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, N.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, N.C","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041019143","display_name":"Sonia Thomas","orcid":"https://orcid.org/0000-0003-1362-5627","observed_orcids":["https://orcid.org/0000-0003-1362-5627"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonia M. Davis","raw_affiliation_strings":["Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill","Quintiles, Research Triangle Park, N.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Quintiles, Research Triangle Park, N.C","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109940472","display_name":"CLARENCE E. DAVIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clarence E. Davis","raw_affiliation_strings":["Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053223016","display_name":"Barry D. Lebowitz","orcid":"https://orcid.org/0000-0002-6467-646X","observed_orcids":["https://orcid.org/0000-0002-6467-646X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry D. Lebowitz","raw_affiliation_strings":["Division of Services and Intervention Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Md"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Services and Intervention Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Md","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108243598","display_name":"Joanne B. Severe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Severe","raw_affiliation_strings":["Division of Services and Intervention Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Md"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Services and Intervention Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Md","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036507830","display_name":"John Hsiao","orcid":"https://orcid.org/0000-0003-3471-7539","observed_orcids":["https://orcid.org/0000-0003-3471-7539"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John K. Hsiao","raw_affiliation_strings":["Division of Services and Intervention Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Md"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Services and Intervention Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Md","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":236.6971,"has_fulltext":true,"cited_by_count":5889,"citation_normalized_percentile":{"value":1.0,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"353","issue":"12","first_page":"1209","last_page":"1223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6930000185966492},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8389999866485596},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8539999723434448},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.9010000228881836},{"id":"https://openalex.org/keywords/perphenazine","display_name":"perphenazine","score":0.8460000157356262},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.996999979019165},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9649999737739563},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4830000102519989},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6620000004768372},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.8479999899864197},{"id":"https://openalex.org/keywords/metabolic-effects","display_name":"metabolic effects","score":0.7310000061988831},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9860000014305115},{"id":"https://openalex.org/keywords/chronic-schizophrenia","display_name":"chronic schizophrenia","score":0.4970000088214874},{"id":"https://openalex.org/keywords/double-blind-comparison","display_name":"double-blind comparison","score":0.47600001096725464},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.9791930913925171},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9224795699119568},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.9175615906715393},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8633926510810852},{"id":"https://openalex.org/C2776743534","wikidata":"https://www.wikidata.org/wiki/Q423520","display_name":"Perphenazine","level":2,"score":0.8494611978530884},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8107494711875916},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7736276388168335},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.701995849609375},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4632725715637207},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.46175503730773926},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.41345447301864624},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.4040200710296631},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3329044282436371},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32544729113578796},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32014816999435425}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010546","descriptor_name":"Perphenazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1056/nejmoa051688","doi":"https://doi.org/10.1056/nejmoa051688","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa051688","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa051688?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:16172203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16172203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1056/nejmoa051688","doi":"https://doi.org/10.1056/nejmoa051688","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa051688","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa051688?articleTools=true","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7799999713897705,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1121004391","display_name":null,"funder_award_id":"N01 MH90001","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G8700482840","display_name":null,"funder_award_id":"MH90001","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320310281","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666"},{"id":"https://openalex.org/F4320318439","display_name":"Foundation of Hope for Research and Treatment of Mental Illness","ror":"https://ror.org/036brtn72"},{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337601","display_name":"Janssen Pharmaceuticals","ror":"https://ror.org/03qd7mz70"},{"id":"https://openalex.org/F4320337683","display_name":"School of Medicine, University of North Carolina at Chapel Hill","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2159155203.pdf","grobid_xml":"https://content.openalex.org/works/W2159155203.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1638784138","https://openalex.org/W1963015295","https://openalex.org/W1981210131","https://openalex.org/W1988672159","https://openalex.org/W1990247209","https://openalex.org/W2000978410","https://openalex.org/W2019029648","https://openalex.org/W2022787364","https://openalex.org/W2024129324","https://openalex.org/W2041474698","https://openalex.org/W2051108113","https://openalex.org/W2053550022","https://openalex.org/W2081069399","https://openalex.org/W2085360366","https://openalex.org/W2096635847","https://openalex.org/W2098132738","https://openalex.org/W2103972533","https://openalex.org/W2106072684","https://openalex.org/W2107538941","https://openalex.org/W2109481947","https://openalex.org/W2111105929","https://openalex.org/W2113319228","https://openalex.org/W2115012618","https://openalex.org/W2115115146","https://openalex.org/W2132980997","https://openalex.org/W2145056060","https://openalex.org/W2151622084","https://openalex.org/W2162993517","https://openalex.org/W2166256285","https://openalex.org/W2168875379","https://openalex.org/W2169490447","https://openalex.org/W3147894994"],"related_works":["https://openalex.org/W2354463463","https://openalex.org/W2373645357","https://openalex.org/W2088052920","https://openalex.org/W2068370991","https://openalex.org/W2180693160","https://openalex.org/W2116225616","https://openalex.org/W2028974493","https://openalex.org/W4242468065","https://openalex.org/W2112815323","https://openalex.org/W1990446812"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,114,189,225,267],"relative":[2],"effectiveness":[3,124],"of":[4,13,46,125,133,143,155,162,169,176,184,194,230,269,296,299,304,314,330],"second-generation":[5],"(atypical)":[6],"antipsychotic":[7,307],"drugs":[8,38],"as":[9],"compared":[10,30],"with":[11,35,49,247,260,322],"that":[12,313],"older":[14],"agents":[15,22],"has":[16],"been":[17],"incompletely":[18],"addressed,":[19],"though":[20],"newer":[21,37],"are":[23],"currently":[24],"used":[25],"far":[26],"more":[27,248,261],"commonly.":[28],"We":[29],"a":[31,40],"first-generation":[32],"antipsychotic,":[33],"perphenazine,":[34,166],"several":[36],"in":[39,121,202,207,217,271,294,328],"double-blind":[41],"study.":[42],"METHODS:":[43],"A":[44],"total":[45],"1493":[47],"patients":[48,134,146,270],"schizophrenia":[50],"were":[51,234],"recruited":[52],"at":[53,149],"57":[54],"U.S.":[55],"sites":[56],"and":[57,111,181,256,301,317,326,332],"randomly":[58],"assigned":[59,157,164,171,178,186,276],"to":[60,64,71,78,86,93,98,118,158,165,172,179,187,191,227,279,312],"receive":[61],"olanzapine":[62,204,244],"(7.5":[63],"30":[65],"mg":[66,73,80,88,100],"per":[67,74,81,89,101],"day),":[68,75,82],"perphenazine":[69,219,257,309],"(8":[70],"32":[72],"quetiapine":[76,209],"(200":[77],"800":[79],"or":[83,211,221,253,281,285],"risperidone":[84,212],"(1.5":[85],"6.0":[87],"day)":[90,102],"for":[91,196,250,263,286],"up":[92],"18":[94,140],"months.":[95],"Ziprasidone":[96],"(40":[97],"160":[99],"was":[103,117,199,245,258,290,320],"included":[104],"after":[105],"its":[106],"approval":[107],"by":[108],"the":[109,122,136,144,192,203,208,218,237,240,291,297,302,305],"Food":[110],"Drug":[112],"Administration.":[113],"primary":[115],"aim":[116],"delineate":[119],"differences":[120],"overall":[123],"these":[126],"five":[127],"treatments.":[128],"RESULTS:":[129],"Overall,":[130],"74":[131,174],"percent":[132,154,161,168,175,183],"discontinued":[135,274],"study":[137],"medication":[138],"before":[139],"months":[141],"(1061":[142],"1432":[145],"who":[147],"received":[148],"least":[150],"one":[151],"dose):":[152],"64":[153],"those":[156,163,170,177,185],"olanzapine,":[159],"75":[160],"82":[167],"quetiapine,":[173,315],"risperidone,":[180,316],"79":[182],"ziprasidone.":[188,318],"time":[190],"discontinuation":[193,228,249,262],"treatment":[195,277],"any":[197],"cause":[198],"significantly":[200],"longer":[201],"group":[205,273],"than":[206],"(P<0.001)":[210],"(P=0.002)":[213],"group,":[214],"but":[215,239],"not":[216],"(P=0.021)":[220],"ziprasidone":[222],"(P=0.028)":[223],"group.":[224],"times":[226],"because":[229],"intolerable":[231,282],"side":[232,283],"effects":[233,284],"similar":[235,311],"among":[236],"groups,":[238],"rates":[241,298],"differed":[242],"(P=0.04);":[243],"associated":[246,259,321],"weight":[251,324],"gain":[252,325],"metabolic":[254],"effects,":[255],"extrapyramidal":[264],"effects.":[265],"CONCLUSIONS:":[266],"majority":[268],"each":[272],"their":[275],"owing":[278],"inefficacy":[280],"other":[287],"reasons.":[288],"Olanzapine":[289,319],"most":[292],"effective":[293],"terms":[295],"discontinuation,":[300],"efficacy":[303],"conventional":[306],"agent":[308],"appeared":[310],"greater":[323],"increases":[327],"measures":[329],"glucose":[331],"lipid":[333],"metabolism.":[334]},"counts_by_year":[{"year":2026,"cited_by_count":86},{"year":2025,"cited_by_count":89},{"year":2024,"cited_by_count":134},{"year":2023,"cited_by_count":129},{"year":2022,"cited_by_count":191},{"year":2021,"cited_by_count":166},{"year":2020,"cited_by_count":338},{"year":2019,"cited_by_count":207},{"year":2018,"cited_by_count":211},{"year":2017,"cited_by_count":220},{"year":2016,"cited_by_count":231},{"year":2015,"cited_by_count":274},{"year":2014,"cited_by_count":325},{"year":2013,"cited_by_count":361},{"year":2012,"cited_by_count":379}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2025-10-10T00:00:00"}